We previously reported that
3'-sulfoquinovosyl-1'-monoacylglycerol (SQMG) effectively suppresses the growth of solid
tumors, likely via its anti-angiogenic activity. To investigate how SQMG affects angiogenesis, we performed
DNA microarray analysis and quantitative real-time polymerase chain reaction. Consequently, upregulation of
thrombospondin 1 (TSP-1) in SQMG-treated
tumors in vitro and in vivo was confirmed. To address the mechanisms of
TSP-1 upregulation by SQMG, we established stable TSP-1-knockdown transformants (TSP1-KT) by
short hairpin RNA induction and performed reporter assay and in vivo assessment of anti-
tumor assay. On the reporter assay, transcriptional upregulation of
TSP-1 in TSP1-KT could not be induced by SQMG, thus suggesting that
TSP-1 upregulation by SQMG occurred via
TSP-1 molecule. In addition, growth of TSP1-KT xenografted
tumors in vivo was not inhibited by SQMG, thus suggesting that anti-angiogenesis via
TSP-1 upregulation induced by SQMG did not occur, as the SQMG target molecule
TSP-1 was knocked down in TSP1-KT transformants. These data provide that SQMG is a promising candidate for the treatment of
tumor-induced angiogenesis via
TSP-1 upregulation.